Skip to main content
Clinical Trials/EUCTR2013-001540-60-DK
EUCTR2013-001540-60-DK
Active, not recruiting
Phase 1

A novel approach to assess gastrointestinal adverse effects of opioids

Mech-Sense, Aalborg University Hospital0 sitesAugust 1, 2013

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Opioid-induced bowel dysfunction.
Sponsor
Mech-Sense, Aalborg University Hospital
Status
Active, not recruiting
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 1, 2013
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
Mech-Sense, Aalborg University Hospital

Eligibility Criteria

Inclusion Criteria

  • Signed informed consent.
  • Able to read and understand Danish.
  • Male of Northern European descent (in order to minimize genetic variance in the study population).
  • The researcher believes that the subject understands the study details, is compliant and is expected to complete the study.
  • Opioid naïve
  • Between 20 and 60 years of age.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) yes
  • F.1\.2\.1 Number of subjects for this age range 70

Exclusion Criteria

  • Known allergy towards pharmaceutical compounds similar to those used in the study.
  • Participation in other studies within 14 days prior to first visit.
  • Expected need of medical/surgical treatment during the course of the study.
  • Any disease, which investigator concludes will affect the trial.
  • History of substance abuse.
  • Family history of substance abuse.
  • Daily alcohol consumption
  • Daily nicotine consumption (e.g. cigarette smoking, nicotine patch, etc.).
  • Need to operate motor vehicle within the study periods.
  • Metal implants or pacemaker.

Outcomes

Primary Outcomes

Not specified

Similar Trials